SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Solvonis Therapeutics Receives US Patent Allowance for Ketamine Treatment Method

The USPTO allowed Solvonis Therapeutics’ method-of-use patent application for treating behavioural addictions with ketamine at dissociative doses of at least 50 mg. Claims include binge eating, gambling, gaming and compulsive sexual behaviour disorders.

SVNS
SquawkNews Desk

Related stories

US Air Travel Disruptions Continue for Third Day, 5,200 Flights Affected More than 5,200 flights had been affected by Sunday as airlines worked to restore schedules. Transportation Secretary Sean Duffy predicted a return to normal by Monday. M impact | EQUITY | Nov 15, 2026, 04:45 PM UTC Duffy Says US Air Travel Disruption Will End by Tomorrow Transportation Secretary Sean Duffy told NBC the disruption would be over by the end of today or tomorrow. L impact | EQUITY | Nov 15, 2026, 02:24 PM UTC US Air Travel Disruption Expected to End by Tomorrow, Duffy Says Transportation Secretary Sean Duffy told NBC the US air travel disruption will be over by the end of today or tomorrow. L impact | EQUITY | Nov 15, 2026, 02:05 PM UTC Transportation Secretary Duffy Says US Air Travel Disruption Will End Soon Duffy told NBC the disruption would be over by “end of today, end of tomorrow.” L impact | EQUITY | Nov 15, 2026, 02:05 PM UTC ESS Tech Files for Chapter 7 Bankruptcy and Ceases Operations ESS Tech filed for Chapter 7 bankruptcy and terminated all employees and officers without cause. The iron flow battery company said it took the action after considering available s M impact | EQUITY | Nov 15, 2026, 02:04 PM UTC BMW Recalls 720,796 US Vehicles Over Potential Fire Risk The recall affects several BMW models manufactured between 2012 and 2018. Safety regulators are asking owners to park affected vehicles outside and away from buildings until the pr M impact | EQUITY | Nov 15, 2026, 02:03 PM UTC